Excluding Orphan Drugs from the 340B Drug Discount Program: the Impact on 18 Critical Access Hospitals

Excluding Orphan Drugs from the 340B Drug Discount Program: the Impact on 18 Critical Access Hospitals

Show other versions (1)

Purpose: The 340B Drug Pricing Program is a federal program designed to reduce the amount that safety net providers spend on outpatient drugs. The Patient Protection and Affordable Health Care Act of 2010 extended eligibility for 340B to critical access hospitals (CAHs) for all drugs except those d...

Full description

Bibliographic Details
Main Authors: Madeline Carpinelli Wallack, Todd Sorensen
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2012-01-01
Series:INNOVATIONS in Pharmacy
Subjects:
340B Drug Discount Program
critical access hospitals
orphan drugs
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/253

Similar Items

Similar Items